Search Results 941-950 of 17322 for labyrinthitis

  1. A Study to Assess The Amyotrophic Lateral Sclerosis (ALS) Patient Experience - Mayo Clinic

    The purpose of this study is to support and extend the results of the FORTITUDE-ALS clinical trial, a clinical trial of an investigational drug (reldesemtiv) ...

  2. Cervical spondylosis - Doctors and departments - Mayo Clinic

    As people age, the spinal disks in the neck shrink and bone spurs often develop. If symptoms occur, nonsurgical treatments are usually effective.

  3. Scleroderma - Doctors and departments - Mayo Clinic

    This group of rare diseases involves the hardening and tightening of the skin and connective tissues. Some forms can affect internal organs.

  4. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. Dural arteriovenous fistulas - Doctors and departments - Mayo Clinic

    Learn about these rare, irregular connections that can occur between arteries and veins in the protective covering of the brain and spinal cord.

  6. Peripheral nerve injuries - Doctors and departments - Mayo Clinic

    These types of injuries affect the nerves that link the brain and spinal cord to nerves in other parts of the body.

  7. Cervical spondylosis - Doctors and departments - Mayo Clinic

    As people age, the spinal disks in the neck shrink and bone spurs often develop. If symptoms occur, nonsurgical treatments are usually effective.

  8. Mayo Clinic

    There's still time! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & Financial Assistance.

  9. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...